Edwards Lifesciences price target raised to $92 from $88 at Evercore ISI

Evercore ISI raised the firm’s price target on Edwards Lifesciences (EW) to $92 from $88 and keeps an Outperform rating on the shares. The company delivered a “strong” Q3 with notable outperformance in its key segments, the analyst tells investors in a research note. The firm added that the Q3 results underscore a positive trajectory for Edwards, particularly with the momentum in transcatheter aortic valve replacements and potential catalysts from National Coverage Determination changes.